Update shared on 03 Nov 2025
Fair value Increased 16%Analysts have raised their price target for Acutaas Chemicals from $1,516.33 to $1,765.17, citing improved profit margin forecasts and a slight increase in expected revenue growth.
What's in the News
- A board meeting is scheduled for October 17, 2025, to approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2025 (Key Developments).
- The board meeting held on August 29, 2025, focused on approving the notice for the 18th annual general meeting, considering the re-appointment of Mr. Nareshkumar Ramjibhai Patel as executive chairman and managing director for another five-year term effective May 1, 2026, and addressing other business matters (Key Developments).
Valuation Changes
- Fair Value: Increased from ₹1,516.33 to ₹1,765.17. This reflects an upward revision in the company's estimated intrinsic worth.
- Discount Rate: Remains unchanged at 12.73 percent, indicating no shift in perceived risk or required rate of return.
- Revenue Growth: Projected growth has risen slightly from 33.05 percent to 33.16 percent.
- Net Profit Margin: Improved significantly from 17.58 percent to 23.44 percent, suggesting stronger profitability expectations.
- Future P/E: Lowered from 41.94x to 37.07x. This indicates expectations of improved earnings or a more attractive valuation.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.